Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04720235 · ClinicalTrials.gov registry record · NA
A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit
A NA study of COVID-19 and Corona Virus Infection, sponsored by Lucira Health.
- Completed
- Registry status
- NA
- Development phase
- 304
- Enrollment target
- 1
- Study location
NCT04720235: Completed NA study of COVID-19 and Corona Virus Infection, sponsored by Lucira Health.
NCT04720235 is a NA study of COVID-19 and Corona Virus Infection that has completed, run by Lucira Health. The registered enrollment target is 304 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04720235, a NA study of COVID-19 and Corona Virus Infection, has completed, sponsored by Lucira Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the performance of the FDA EUA authorized Lucira COVID-19 All-In-One Test Kit for the qualitative detection of SARS-CoV-2 virus in nasal swab samples as compared to a known high sensitivity EUA RT-PCR among asymptomatic individuals. The comparator assay for this study is the Hologic Panther Fusion SARS-CoV-2 RT-PCR Assay.
Primary Outcome
Study prevalence of SARS-CoV-2 will be summarized by counts and grouped by age
Conditions Studied
Interventions
- DEVICE Lucira COVID-19 All-In-One test kit
Study Locations (1)
California
- Neeraj Kochhar Family Medicine - Los Gatos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2021-03-30 |
| Phase | NA |
What the finished NCT04720235 record still lists
NCT04720235 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Lucira COVID-19 All-In-One test kit is the first listed.
NCT04720235 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04720235 about?
NCT04720235 is a clinical study titled "A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit". To evaluate the performance of the FDA EUA authorized Lucira COVID-19 All-In-One Test Kit for the qualitative detection of SARS-CoV-2 virus in nasal swab samples as compared to a known high sensitivity EUA RT-PCR among asymptomatic individuals. The comparator assay for this study is the Hologic Pant...
What is the current status of trial NCT04720235?
This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2020-12-09. Estimated completion is 2021-03-30.
What conditions does trial NCT04720235 study?
This clinical trial studies the following conditions: COVID-19, Corona Virus Infection.
What interventions are being tested in trial NCT04720235?
The interventions under investigation include: Lucira COVID-19 All-In-One test kit (DEVICE).
Who is sponsoring clinical trial NCT04720235?
This trial is sponsored by Lucira Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04720235 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04720235's enrollment target sits among peer trials
304 138th of 298 higher than 161 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI